{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:55:59Z","timestamp":1790484959241,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"crossref","award":["RGPIN-2014-04354"],"award-info":[{"award-number":["RGPIN-2014-04354"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","award":["MOP-119361"],"award-info":[{"award-number":["MOP-119361"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","nucmedbio.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.nucmedbio.2017.10.006","type":"journal-article","created":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T19:52:23Z","timestamp":1508788343000},"page":"31-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Evaluation of a novel GRPR antagonist for prostate cancer PET imaging: [ 64 Cu]-DOTHA 2 -PEG-RM26"],"prefix":"10.1016","volume":"56","author":[{"given":"Nematallah","family":"Mansour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Paquette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia","family":"Ait-Mohand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Dumulon-Perreault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Gu\u00e9rin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2017.10.006_bb0005","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1039\/C3CS60304K","article-title":"Matching chelators to radiometals for radiopharmaceuticals","volume":"43","author":"Price","year":"2014","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.nucmedbio.2017.10.006_bb0010","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3389\/fonc.2013.00247","article-title":"Peptides in receptor-mediated radiotherapy: from design to the clinical application in cancers","volume":"3","author":"Lozza","year":"2013","journal-title":"Front Oncol"},{"key":"10.1016\/j.nucmedbio.2017.10.006_bb0015","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.nucmedbio.2014.12.009","article-title":"The effect of macrocyclic chelators on the targeting properties of the 68Ga-labeled gastrin releasing peptide receptor antagonist PEG2-RM26","volume":"42","author":"Varasteh","year":"2015","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2017.10.006_bb0020","first-page":"9","article-title":"The copper radioisotopes: a systematic review with special interest to 64Cu","author":"Asabella","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.nucmedbio.2017.10.006_bb0025","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1089\/cbr.2009.0674","article-title":"Copper-64 radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research","volume":"24","author":"Anderson","year":"2009","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.nucmedbio.2017.10.006_bb0030","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.nucmedbio.2008.09.001","article-title":"Evaluation of novel bifunctional chelates for the development of Cu-64-based radiopharmaceuticals","volume":"35","author":"Ferreira","year":"2008","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2017.10.006_bb0035","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1021\/bc300037w","article-title":"Comparison of (64)Cu-complexing bifunctional chelators for radioimmunoconjugation: labeling efficiency, specific activity, and in vitro\/in vivo stability","volume":"23","author":"Cooper","year":"2012","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nucmedbio.2017.10.006_bb0040","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.nucmedbio.2012.05.009","article-title":"Copper-64 radiolabeling and biological evaluation of bifunctional chelators for radiopharmaceutical development","volume":"39","author":"De Silva","year":"2012","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2017.10.006_bb0045","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1039\/C3CC45928D","article-title":"New cross-bridged cyclam derivative CB-TE1K1P, an improved bifunctional chelator for copper radionuclides","volume":"50","author":"Zeng","year":"2014","journal-title":"Chem Commun"},{"key":"10.1016\/j.nucmedbio.2017.10.006_bb0050","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.nucmedbio.2008.12.008","article-title":"64Cu-Labeled CB-TE2A and diamsar-conjugated RGD peptide analogs for targeting angiogenesis: comparison of their biological activity","volume":"36","author":"Wei","year":"2009","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2017.10.006_bb0055","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1021\/ol5020575","article-title":"Development of bifunctional chelates bearing hydroxamate arms for highly efficient 64Cu radiolabeling","volume":"16","author":"Ait-Mohand","year":"2014","journal-title":"Org Lett"},{"key":"10.1016\/j.nucmedbio.2017.10.006_bb0060","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1021\/bc3002437","article-title":"Novel radiolabeled peptides for breast and prostate tumor PET imaging: (64)Cu\/and (68)Ga\/NOTA-PEG-[D-Tyr(6),betaAla(11),Thi(13),Nle(14)]BBN(6-14)","volume":"23","author":"Fournier","year":"2012","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nucmedbio.2017.10.006_bb0065","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1021\/bc2002665","article-title":"Evaluation of 64Cu-labeled bifunctional chelate-bombesin conjugates","volume":"22","author":"Ait-Mohand","year":"2011","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nucmedbio.2017.10.006_bb0070","first-page":"1390","article-title":"MicroPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts","volume":"45","author":"Chen","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2017.10.006_bb0075","doi-asserted-by":"crossref","first-page":"12462","DOI":"10.1073\/pnas.0705347104","article-title":"[64Cu-NOTA-8-Aoc-BBN(7-14)NH2] targeting vector for positron-emission tomography imaging of gastrin-releasing peptide receptor-expressing tissues","volume":"104","author":"Prasanphanich","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nucmedbio.2017.10.006_bb0080","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.nucmedbio.2010.04.016","article-title":"Optimization, biological evaluation and microPET imaging of copper-64-labeled bombesin agonists, [64Cu-NO2A-(X)-BBN(7-14)NH2], in a prostate tumor xenografted mouse model","volume":"37","author":"Lane","year":"2010","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2017.10.006_bb0085","first-page":"71","article-title":"Peptides as carrier for tumor diagnosis and treatment","volume":"1","author":"Langer","year":"2001","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.nucmedbio.2017.10.006_bb0090","first-page":"583","article-title":"Positron-emission tomography (PET) imaging agents for diagnosis of human prostate cancer: agonist vs. antagonist ligands","volume":"26","author":"Nanda","year":"2012","journal-title":"In Vivo"},{"key":"10.1016\/j.nucmedbio.2017.10.006_bb0095","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1021\/bc800290c","article-title":"Design, synthesis, and biological evaluation of an antagonist-bombesin analogue as targeting vector","volume":"19","author":"Abd-Elgaliel","year":"2008","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nucmedbio.2017.10.006_bb0100","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.2967\/jnumed.111.087999","article-title":"PET of somatostatin receptor-positive tumors using 64Cu- and 68Ga-somatostatin antagonists: the chelate makes the difference","volume":"52","author":"Fani","year":"2011","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2017.10.006_bb0105","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.2967\/jnumed.108.054502","article-title":"Preparation and biological evaluation of 64Cu-CB-TE2A-sst2-ANT, a somatostatin antagonist for PET imaging of somatostatin receptor-positive tumors","volume":"49","author":"Wadas","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2017.10.006_bb0110","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.2967\/jnumed.111.094375","article-title":"Bombesin antagonist-based radioligands for translational nuclear imaging of gastrin-releasing peptide receptor-positive tumors","volume":"52","author":"Abiraj","year":"2011","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2017.10.006_bb0115","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0006-2952(95)02122-1","article-title":"Radiolabelling of the human 5-HT2A receptor with an agonist, a partial agonist and an antagonist: Effects on apparent agonist affinities","volume":"51","author":"Sleight","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.nucmedbio.2017.10.006_bb0120","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0022-3565(24)38013-9","article-title":"Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors","volume":"288","author":"Perrin","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.nucmedbio.2017.10.006_bb0125","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/sj.bjp.0706697","article-title":"[3H]GR205171 displays similar NK1 receptor binding profile in gerbil and human brain","volume":"148","author":"Griffante","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.nucmedbio.2017.10.006_bb0130","doi-asserted-by":"crossref","first-page":"16436","DOI":"10.1073\/pnas.0607761103","article-title":"Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors","volume":"103","author":"Ginj","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nucmedbio.2017.10.006_bb0135","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2967\/jnumed.107.045054","article-title":"Bombesin receptor antagonists may be preferable to agonists for tumor targeting","volume":"49","author":"Cescato","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2017.10.006_bb0140","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1034\/j.1399-3011.1999.00028.x","article-title":"Syntheses and biological activities of potent bombesin receptor antagonists","volume":"53","author":"Llinares","year":"1999","journal-title":"J Pept Res"},{"key":"10.1016\/j.nucmedbio.2017.10.006_bb0145","first-page":"1","article-title":"Impact of dianionic and dicationic linkers on tumor uptake and biodistribution of [64Cu]Cu\/NOTA peptide-based GRPR antagonists","author":"Mansour","year":"2017","journal-title":"J Labelled Comp Radiopharm"},{"key":"10.1016\/j.nucmedbio.2017.10.006_bb0150","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1162\/153535003322556877","article-title":"AMIDE: a free software tool for multimodality medical image analysis","volume":"2","author":"Loening","year":"2003","journal-title":"Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2017.10.006_bb0155","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0076-6879(04)86011-7","article-title":"Production and applications of copper-64 radiopharmaceuticals","volume":"386","author":"Sun","year":"2004","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.nucmedbio.2017.10.006_bb0160","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/ejoc.201301499","article-title":"Synthesis and evaluation of an enantiomerically enriched bifunctional chelator for 64Cu-based positron emission tomography (PET) imaging","author":"Chong","year":"2014","journal-title":"Eur J Org Chem"},{"key":"10.1016\/j.nucmedbio.2017.10.006_bb0165","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1021\/jm030383m","article-title":"Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes","volume":"47","author":"Boswell","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2017.10.006_bb0170","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1007\/s00259-010-1506-1","article-title":"Comparison of bifunctional chelates for 64Cu antibody imaging","volume":"37","author":"Ferreira","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2017.10.006_bb0175","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1021\/bc900537f","article-title":"Evaluation of copper-64 labeled AmBaSar conjugated cyclic RGD peptide for improved MicroPET imaging of integrin \u03b1v\u03b23 expression","volume":"21","author":"Cai","year":"2010","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nucmedbio.2017.10.006_bb0180","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1021\/mp400686z","article-title":"Pycup \u2014 a bifunctional, cage-like ligand for 64Cu radiolabeling","volume":"11","author":"Boros","year":"2014","journal-title":"Mol Pharm"},{"key":"10.1016\/j.nucmedbio.2017.10.006_bb0185","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1039\/C1DT11743B","article-title":"Synthesis, Cu(II) complexation, 64Cu-labeling and biological evaluation of cross-bridged cyclam chelators with phosphonate pendant arms","volume":"41","author":"Ferdani","year":"2012","journal-title":"Dalton Trans"},{"key":"10.1016\/j.nucmedbio.2017.10.006_bb0190","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.2967\/jnumed.111.087700","article-title":"Novel 64Cu and 68Ga-labeled RGD conjugates show improved PET imaging of \u03b1v\u03b23 integrin expression and facile radiosynthesis","volume":"52","author":"Dumont","year":"2011","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2017.10.006_bb0195","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1002\/hlca.19860690830","article-title":"Metal complexes of macrocyclic ligands. Part XXIII. Synthesis, properties, and structures of mononuclear complexes with 12- and 14-membered tetraazamacrocycle-N,N',N''N'''-tetraacetic acids","volume":"69","author":"Riesen","year":"1986","journal-title":"Helv Chim Acta"},{"key":"10.1016\/j.nucmedbio.2017.10.006_bb0200","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13550-016-0160-4","article-title":"Imaging heterogeneity of peptide delivery and binding in solid tumors using SPECT imaging and MRI","volume":"6","author":"Haeck","year":"2016","journal-title":"EJNMMI Res"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805117300574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805117300574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T17:49:19Z","timestamp":1750960159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805117300574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":40,"alternative-id":["S0969805117300574"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2017.10.006","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of a novel GRPR antagonist for prostate cancer PET imaging: [64Cu]-DOTHA2-PEG-RM26","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2017.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}